6WHO image
Entry Detail
PDB ID:
6WHO
Title:
Histone deacetylases complex with peptide macrocycles
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2020-04-08
Release Date:
2021-04-21
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.22
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Histone deacetylase 2
Chain IDs:A, B, C
Chain Length:385
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:U2M-ASN-PRO-GLU-GLN-DLY-TRP-GLY peptide macrocycle
Chain IDs:D (auth: F), E (auth: G), F (auth: H)
Chain Length:8
Number of Molecules:3
Biological Source:synthetic construct
Primary Citation
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites.
Nat Commun 12 3384 3384 (2021)
PMID: 34099674 DOI: 10.1038/s41467-021-23609-8

Abstact

Despite recent success in computational design of structured cyclic peptides, de novo design of cyclic peptides that bind to any protein functional site remains difficult. To address this challenge, we develop a computational "anchor extension" methodology for targeting protein interfaces by extending a peptide chain around a non-canonical amino acid residue anchor. To test our approach using a well characterized model system, we design cyclic peptides that inhibit histone deacetylases 2 and 6 (HDAC2 and HDAC6) with enhanced potency compared to the original anchor (IC50 values of 9.1 and 4.4 nM for the best binders compared to 5.4 and 0.6 µM for the anchor, respectively). The HDAC6 inhibitor is among the most potent reported so far. These results highlight the potential for de novo design of high-affinity protein-peptide interfaces, as well as the challenges that remain.

Legend

Protein

Chemical

Disease

Primary Citation of related structures